KLDO News and Press, Kaleido Biosciences Inc. From 06/04/20

LEXINGTON, Mass., June 04, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that Alison Lawton, President and Chief E...

Gainers: Ameri Holdings (NASDAQ: AMRH ) +152% . More news on: Ameri Holdings, Inc., Westwater Resources, Inc., Genius Brands International, Inc., Stocks on the move, , Read more ...

Cemtrex (NASDAQ: CETX )  -26%  on $5.5M direct offering . More news on: Cemtrex, Inc., Digital Ally, Inc., Allied Esports Entertainment Inc., Stocks on the move, , Read more ...

Kaleido Biosciences (NASDAQ: KLDO ) has priced its public offering of 4.75M common shares at $7.50/share, for expected gross proceeds of ~$35.6M. More news on: Kaleido Biosciences, Inc., Healthcare stocks news, , Read more ...

LEXINGTON, Mass., June 01, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced the pricing of an underwritten public off...

LEXINGTON, Mass., June 01, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that it intends to sell, subject to ...

CAMBRIDGE, Mass. , May 28, 2020 /PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has further strengthened its executive leadership team with the appointment of Fabrice Chouraqui to the newly created dual role as both CEO-Par...

Kaleido Biosciences, Inc. (KLDO) Q1 2020 Earnings Conference Call May 14, 2020 8:30 AM ET Company Participants Amy Reilly - Vice President of Communications & Investor Relations Mike Bonney - Executive Chair Alison Lawton - President & Chief Executive Officer Kate Knobi...

The following slide deck was published by Kaleido Biosciences, Inc. in conjunction with their 2020 Q1 earnings Read more ...

Kaleido Biosciences (NASDAQ: KLDO ): Q1 GAAP EPS of -$0.64 in-line. More news on: Kaleido Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...